ZA200709870B - Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity - Google Patents

Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity

Info

Publication number
ZA200709870B
ZA200709870B ZA200709870A ZA200709870A ZA200709870B ZA 200709870 B ZA200709870 B ZA 200709870B ZA 200709870 A ZA200709870 A ZA 200709870A ZA 200709870 A ZA200709870 A ZA 200709870A ZA 200709870 B ZA200709870 B ZA 200709870B
Authority
ZA
South Africa
Prior art keywords
antibacterial activity
aminopiperidine
quinolines
azaisosteric
analogues
Prior art date
Application number
ZA200709870A
Other languages
English (en)
Inventor
Reck Folkert
Hartl Hajnalka
Morningstar Marshall
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200709870B publication Critical patent/ZA200709870B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
ZA200709870A 2005-05-24 2007-11-15 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity ZA200709870B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68403005P 2005-05-24 2005-05-24

Publications (1)

Publication Number Publication Date
ZA200709870B true ZA200709870B (en) 2008-11-26

Family

ID=36685663

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200709870A ZA200709870B (en) 2005-05-24 2007-11-15 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity

Country Status (14)

Country Link
US (1) US20090131444A1 (pt)
EP (1) EP1891078A1 (pt)
JP (1) JP2008542249A (pt)
KR (1) KR20080016577A (pt)
CN (1) CN101258157A (pt)
AU (1) AU2006250987A1 (pt)
BR (1) BRPI0609887A2 (pt)
CA (1) CA2608072A1 (pt)
IL (1) IL187134A0 (pt)
MX (1) MX2007014507A (pt)
NO (1) NO20076675L (pt)
RU (1) RU2007147413A (pt)
WO (1) WO2006125974A1 (pt)
ZA (1) ZA200709870B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
CA2643962A1 (en) * 2006-03-10 2007-09-20 Actelion Pharmaceuticals Ltd Antibiotic compounds
WO2007115947A1 (en) 2006-04-06 2007-10-18 Glaxo Group Limited Pyrrolo-quinoxalinone derivatives as antibacterials
JP5171618B2 (ja) 2006-05-26 2013-03-27 富山化学工業株式会社 新規な複素環化合物またはその塩ならびにその中間体
BRPI0712430A2 (pt) * 2006-06-08 2012-07-03 Speedel Experimenta Ag piperidinas 2,5-di-substitìdas.
AU2008240764C1 (en) * 2007-04-20 2011-10-20 Glaxo Group Limited Tricyclic nitrogen containing compounds as antibacterial agents
ATE520687T1 (de) 2007-06-15 2011-09-15 Actelion Pharmaceuticals Ltd 3-amino-6-(1-amino-ethyl)-tetrahydropyranderiva e
MX2010008922A (es) 2008-02-20 2010-09-07 Actelion Pharmaceuticals Ltd Compuestos antibioticos azatriciclicos.
BRPI0920895A8 (pt) 2008-10-07 2017-12-26 Actelion Pharmaceuticals Ltd Compostos antibióticos de oxazolidinona tricíclica
WO2010043714A1 (en) 2008-10-17 2010-04-22 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
ES2435596T3 (es) 2008-12-12 2013-12-20 Actelion Pharmaceuticals Ltd. Derivados de 5-amino-2-(1-hidroxi-etil)-tetrahidropirano
US20120053350A1 (en) * 2009-04-30 2012-03-01 Ian Mangion Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
SG10201507846YA (en) * 2010-04-02 2015-10-29 Senomyx Inc Sweet flavor modifier
US8829191B2 (en) * 2011-06-17 2014-09-09 Melanie Simone Ronsheim Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
MY179876A (en) 2011-08-12 2020-11-18 Firmenich Incorporated Sweet flavor modifier
US8933232B2 (en) 2012-03-30 2015-01-13 Cubist Pharmaceuticals, Inc. 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
AR090844A1 (es) 2012-04-27 2014-12-10 Actelion Pharmaceuticals Ltd Proceso para elaborar derivados de naftiridina
WO2014152996A1 (en) 2013-03-14 2014-09-25 Cubist Pharmaceuticals, Inc. Crystalline form of a beta-lactamase inhibitor
US9120796B2 (en) 2013-10-02 2015-09-01 Cubist Pharmaceuticals, Inc. B-lactamase inhibitor picoline salt
CN103613530B (zh) * 2013-12-02 2015-08-19 江苏弘和药物研发有限公司 一种芴甲氧羰基-3-哌啶醇的合成方法
EP3915975A1 (en) * 2013-12-27 2021-12-01 API Corporation Method for producing 5-hydroxypiperidine-2-carboxylic acid
EA031589B1 (ru) 2014-08-22 2019-01-31 Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Трициклические азотсодержащие соединения для лечения инфекции, вызываемой neisseria gonorrhoeae
WO2016073251A1 (en) 2014-11-07 2016-05-12 Senomyx, Inc. Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers
UY36851A (es) * 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
HUE049547T2 (hu) 2016-06-08 2020-10-28 Acraf Új baktériumellenes szerek
EP4295852A2 (en) 2016-07-13 2023-12-27 Syros Pharmaceuticals, Inc. Piperidine derivatives as inhibitors of cyclin dependent kinase 7 (cdk7)
JP7210483B2 (ja) 2017-06-30 2023-01-23 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 新規アザキノリン誘導体
MX2020001352A (es) 2017-08-09 2020-03-20 Denali Therapeutics Inc Compuestos, composiciones y metodos.
SI3676297T1 (sl) * 2017-09-01 2023-12-29 Denali Therapeutics Inc. Spojine, sestavki in postopki
TWI802591B (zh) 2017-09-14 2023-05-21 日商第一三共股份有限公司 具有環狀構造的化合物
CR20210426A (es) 2019-02-13 2021-09-30 Denali Therapeutics Inc Compuestos, composiciones y métodos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822450D0 (en) * 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
DE60125373T2 (de) * 2000-07-26 2007-10-18 Smithkline Beecham P.L.C., Brentford Aminopiperidin chinoline und ihre azaisosteren analoga mit antibakterieller wirkung
JP2004509885A (ja) * 2000-09-21 2004-04-02 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー 抗菌薬としてのキノリン誘導体
JP4887297B2 (ja) * 2004-09-24 2012-02-29 アクテリオン ファーマシューティカルズ リミテッド 新規二環式抗生物質

Also Published As

Publication number Publication date
BRPI0609887A2 (pt) 2011-10-11
RU2007147413A (ru) 2009-06-27
IL187134A0 (en) 2008-02-09
EP1891078A1 (en) 2008-02-27
WO2006125974A1 (en) 2006-11-30
KR20080016577A (ko) 2008-02-21
JP2008542249A (ja) 2008-11-27
AU2006250987A1 (en) 2006-11-30
NO20076675L (no) 2007-12-27
US20090131444A1 (en) 2009-05-21
MX2007014507A (es) 2008-02-07
CN101258157A (zh) 2008-09-03
CA2608072A1 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
IL187134A0 (en) Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
HK1124784A1 (en) Quinolines and their pharmaceutic use
IL196152A0 (en) Substituted piperidines that increase p53 activity and the uses thereof
IL188420A0 (en) Methods and compositions with enhanced therapeutic activity
ZA200706793B (en) Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
IL228770A0 (en) processes and intermediates
EP2015781A4 (en) COMPOSITIONS HAVING ANTIANGIOGENIC ACTIVITY AND USES THEREOF
EP1889195A4 (en) PRODUCTION-DESIGN DESIGN AND DESIGNED PRODUCTION
PT1984322E (pt) Derivados de benzamida e heteroareno
EP1878346A4 (en) INORGANIC ANTIBACTERIAL MEDIUM OF SILVER BASE, AND ANTIBACTERIAL PRODUCT
EP1941925A4 (en) PROTECTOR AND NEEDLE SET
HK1125626A1 (en) Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
IL179236A (en) Griffithsin and its antiviral resistant glycosylation variants and related methods
GB0516069D0 (en) Pharmaceutical and use thereof
PT2380575E (pt) Acetato de eslicarbazepina e utilização
IL189252A0 (en) Dihydroxyanthraquinones and their use
HK1121759A1 (zh) 烷基磺酰胺喹啉
IL189849A0 (en) Interferon-beta and optic neuritis
EP1984931A4 (en) PUSH BUTTON ARRANGEMENT AND PUSH BUTTON
EP1869022A4 (en) NAPHTHALAMIDE DERIVATIVES HAVING ANTIPROLIFERATIVE ACTIVITY
ZA200802683B (en) Quinolines and their therapeutic use
IL188241A0 (en) Cripowellins and synthetic derivatives thereof used as medicaments
HRP20040318A2 (en) Furochromen derivative with anti-inflammaroty activity
HK1216635A1 (zh) 具血清素激活及/或去甲腎上腺素活動的代苯乙胺
GB0521886D0 (en) Glycosyltrasferase activity